Breast Cancer,HER2- Neoadjuvant Evaluation of Ganetespib in Stage II/III Breast Cancer Treatment Feb 09, 2023
Breast Cancer,HER2- Phase 3 Trial Analysis on HER2-Negative, Node-Positive Early Breast Cancer With Abemaciclib Plus Endocrine Therapy Effective Feb 09, 2023
